We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Thermo-Conductive System Continuously Measures Body Temperature

By HospiMedica International staff writers
Posted on 23 Sep 2010
A new device continuously monitors patient temperature during intensive care unit (ICU), surgical, recovery room, and general patient settings. More...


The Abreu Brain Temperature Tunnel (BTT) 700 System sensor is a noninvasive device that measures temperature on the skin surface of the BTT, a fat-free skin area located between the eye and eyebrow, which lacks insulation tissue; since the internal portion of the tissue is in direct communication with the brain, temperature can be accurately and continuously monitored with unimpeded transfer of internal thermal energy through the skin.

The system also enables any patient's temperature to be remotely monitored from the nurse's station, reducing the need for nursing staff to check the patients' temperature continuously, including middle-of-the-night temperature checks. In addition, by detecting spikes in infections earlier, cost of treatment can be reduced and the performance of drug therapies can be improved; with better, earlier treatment, the length of hospital stays can be reduced. The Abreu BTT 700 System is a product of Brain Tunnelgenix Technologies (BTT, Hamden, CT, USA), and has been approved by the U.S. Food and Drug Administration (FDA).

"We are excited that medical professionals and researchers will now have access to the first product in history that enables temperature to be continuously monitored on the only truly thermoconductive skin in the body," said Rick Foreman, CEO of BTT. "This breakthrough will enable clinicians to escape their dependence on invasive thermometry and surface measurements across thermal barriers. With the exception of putting a sensor directly inside the brain, studies have shown that the BTT is the only sensor capable of detecting brain hypothermia and harmful cerebral hyperthermia.”

"One of the most important causes of death is hospital infection, which kills more than 100,000 patients a year in the United States,” added the discoverer of the BTT, Marc Abreu, M.D. "The inability to detect temperature changes in a timely fashion can lead to spread of infection and even cause death. Monitoring the brain temperature tunnel can detect infection early, so timely therapy can be administered, and complications prevented.”

Related Links:
Brain Tunnelgenix Technologies



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.